Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 180

1.

Absorption of irrigation fluid during XPS™ GreenLight laser vaporization of the prostate: results from a prospective breath ethanol monitoring study.

Wettstein MS, Poyet C, Grossmann NC, Fankhauser CD, Keller EX, Kozomara M, Meyer S, Sulser T, Müller A, Hermanns T.

World J Urol. 2016 Jan 16. [Epub ahead of print]

PMID:
26780733
2.

Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer.

Poyet C, Hermanns T, Zhong Q, Drescher E, Eberli D, Burger M, Hofstaedter F, Hartmann A, Stöhr R, Zwarthoff EC, Sulser T, Wild PJ.

Oncol Lett. 2015 Nov;10(5):2753-2760. Epub 2015 Sep 9.

3.

Long-Term Oncologic Outcome of an Initial Series of Laparoscopic Radical Prostatectomy for Clinically Localized Prostate Cancer After a Median Follow-up of 10 Years.

Mortezavi A, Sulser T, Robbiani J, Drescher E, Disteldorf D, Eberli D, Poyet C, Baumgartner MK, Seifert HH, Hermanns T.

Clin Genitourin Cancer. 2015 Nov 17. pii: S1558-7673(15)00305-5. doi: 10.1016/j.clgc.2015.11.006. [Epub ahead of print]

PMID:
26710661
4.

Polyesterurethane and acellular matrix based hybrid biomaterial for bladder engineering.

Horst M, Milleret V, Noetzli S, Gobet R, Sulser T, Eberli D.

J Biomed Mater Res B Appl Biomater. 2015 Dec 16. doi: 10.1002/jbm.b.33591. [Epub ahead of print]

PMID:
26669507
5.

[Erectile and Ejaculatory Dysfunction].

Gross O, Sulser T, Eberli D.

Praxis (Bern 1994). 2015 Nov 25;104(24):1337-41. doi: 10.1024/1661-8157/a002194. Review. German.

PMID:
26602851
6.

CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer.

Wettstein MS, Buser L, Hermanns T, Roudnicky F, Eberli D, Baumeister P, Sulser T, Wild P, Poyet C.

Dis Markers. 2015;2015:785461. doi: 10.1155/2015/785461. Epub 2015 Oct 12.

7.

Predictive value of low tube voltage and dual-energy CT for successful shock wave lithotripsy: an in vitro study.

Largo R, Stolzmann P, Fankhauser CD, Poyet C, Wolfsgruber P, Sulser T, Alkadhi H, Winklhofer S.

Urolithiasis. 2015 Sep 21. [Epub ahead of print]

PMID:
26391614
8.

Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary European cohort.

Poyet C, Nieboer D, Bhindi B, Kulkarni GS, Wiederkehr C, Wettstein MS, Largo R, Wild P, Sulser T, Hermanns T.

BJU Int. 2015 Aug 31. doi: 10.1111/bju.13314. [Epub ahead of print]

PMID:
26332503
9.

A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).

Randazzo M, Müller A, Carlsson S, Eberli D, Huber A, Grobholz R, Manka L, Mortezavi A, Sulser T, Recker F, Kwiatkowski M.

BJU Int. 2015 Aug 31. doi: 10.1111/bju.13310. [Epub ahead of print]

PMID:
26332304
10.

Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer.

Poyet C, Buser L, Roudnicky F, Detmar M, Hermanns T, Mannhard D, Höhn A, Rüschoff J, Zhong Q, Sulser T, Moch H, Wild PJ.

J Clin Pathol. 2015 Oct;68(10):819-24. doi: 10.1136/jclinpath-2015-202898. Epub 2015 Aug 6.

11.

High VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer.

Benoit T, Keller EX, Wolfsgruber P, Hermanns T, Günthart M, Banzola I, Sulser T, Provenzano M, Poyet C.

Med Sci Monit. 2015 Aug 4;21:2266-74. doi: 10.12659/MSM.894383.

12.

Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial design.

van den Bos W, Muller BG, de Bruin DM, de Castro Abreu AL, Chaussy C, Coleman JA, Finelli A, Gill IS, Gross ME, Jenniskens SF, Kahmann F, Laguna-Pes MP, Rastinehad AR, Simmons LA, Sulser T, Villers A, Ward JF, de la Rosette JJ.

Urol Oncol. 2015 Nov;33(11):495.e1-7. doi: 10.1016/j.urolonc.2015.06.015. Epub 2015 Jul 29.

PMID:
26231310
13.

Magnetic stimulation supports muscle and nerve regeneration after trauma in mice.

Stölting MN, Arnold AS, Haralampieva D, Handschin C, Sulser T, Eberli D.

Muscle Nerve. 2015 Jul 22. doi: 10.1002/mus.24780. [Epub ahead of print]

PMID:
26202157
14.

Frequent PD-L1 expression in testicular germ cell tumors.

Fankhauser CD, Curioni-Fontecedro A, Allmann V, Beyer J, Tischler V, Sulser T, Moch H, Bode PK.

Br J Cancer. 2015 Jul 28;113(3):411-3. doi: 10.1038/bjc.2015.244. Epub 2015 Jul 14.

PMID:
26171934
15.

Acceptance, Prevalence and Indications for Robot-Assisted Laparoscopy - Results of a Survey Among Urologists in Germany, Austria and Switzerland.

Imkamp F, Herrmann TR, Tolkach Y, Dziuba S, Stolzenburg JU, Rassweiler J, Sulser T, Zimmermann U, Merseburger AS, Kuczyk MA, Burchardt M.

Urol Int. 2015 Nov;95(3):336-45. doi: 10.1159/000430502. Epub 2015 Jul 8.

PMID:
26160360
16.

Long-term Adverse Effects of Extracorporeal Shock-wave Lithotripsy for Nephrolithiasis and Ureterolithiasis: A Systematic Review.

Fankhauser CD, Kranzbühler B, Poyet C, Hermanns T, Sulser T, Steurer J.

Urology. 2015 May;85(5):991-1006. doi: 10.1016/j.urology.2014.12.014. Review.

PMID:
25917723
17.

Antibody response to BK polyomavirus as a prognostic biomarker and potential therapeutic target in prostate cancer.

Keller XE, Kardas P, Acevedo C, Sais G, Poyet C, Banzola I, Mortezavi A, Seifert B, Sulser T, Hirsch HH, Provenzano M.

Oncotarget. 2015 Mar 20;6(8):6459-69.

18.

CD10 expression in 325 testicular germ cell tumours.

Fankhauser CD, Sulser T, Zhong Q, Barghorn A, Moch H, Bode PK.

J Clin Pathol. 2015 May;68(5):400-3. doi: 10.1136/jclinpath-2014-202806. Epub 2015 Feb 23. No abstract available. Erratum in: J Clin Pathol. 2015 Jul;68(7):e2.

PMID:
25713420
19.

pVHL/HIF-regulated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma.

Ruf M, Mittmann C, Nowicka AM, Hartmann A, Hermanns T, Poyet C, van den Broek M, Sulser T, Moch H, Schraml P.

Clin Cancer Res. 2015 Feb 15;21(4):889-98. doi: 10.1158/1078-0432.CCR-14-1425.

PMID:
25691774
20.

Differentiated adipose-derived stem cells for bladder bioengineering.

Salemi S, Tremp M, Plock JA, Andersson KE, Gobet R, Sulser T, Eberli D.

Scand J Urol. 2015 Oct;49(5):407-14. doi: 10.3109/21681805.2015.1004642. Epub 2015 Feb 4.

PMID:
25652651
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk